Back
ProShares UltraPro S&P500 Vs. PTC Therapeutics Industry Stock Comparison
Buy
63
UPRO
ProShares UltraPro S&P500
Last Price:
79.75
Seasonality Move:
5.49%
Sell
34
PTCT
PTC Therapeutics
Last Price:
30.99
Seasonality Move:
8.11%
Buy
63
ProShares UltraPro S&P500 (UPRO)
is a Buy
Is ProShares UltraPro S&P500 a Buy, Sell or Hold?
- The current ProShares UltraPro S&P500 [UPRO] share price is $78.79. The Score for UPRO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- UPRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.39. The Score for PTCT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UPRO Stock Price Chart
What is ProShares UltraPro S&P500's stock price today?
-
The ProShares UltraPro S&P500 share price today is $78.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight selling pressure.
UPRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.02 | Buy |
| Relative Strength Index (14 RSI): | 69.03 | Buy |
| Chaikin Money Flow: | 2817495 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.56 - 77.84) | Buy |
| Bollinger Bands (100): | (63.25 - 73.25) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 35.32 | Sell |
| Chaikin Money Flow: | -285238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.46 - 37.72) | Sell |
| Bollinger Bands (100): | (26.79 - 35.21) | Sell |
UPRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.44 | Buy |
| 20-day SMA: | 75.88 | Buy |
| 50-day SMA: | 70.76 | Buy |
| 200-day SMA: | 58.28 | Buy |
| 8-day EMA: | 77.47 | Buy |
| 20-day EMA: | 75.8 | Buy |
| 50-day EMA: | 72.21 | Buy |
| 200-day EMA: | 61.33 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.66 | Sell |
| 20-day SMA: | 35.43 | Sell |
| 50-day SMA: | 34.01 | Sell |
| 200-day SMA: | 27.58 | Buy |
| 8-day EMA: | 32.88 | Sell |
| 20-day EMA: | 34.35 | Sell |
| 50-day EMA: | 33.7 | Sell |
| 200-day EMA: | 31.8 | Sell |
ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
ProShares UltraPro S&P500 Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||